key: cord-1034058-rpcrjgmi
authors: Yam, Esabelle Lo Yan
title: COVID-19 will further exacerbate global antimicrobial resistance
date: 2020-06-13
journal: J Travel Med
DOI: 10.1093/jtm/taaa098
sha: 1f49991e714284d9101bc4351c1f7dc5fe5ea9d2
doc_id: 1034058
cord_uid: rpcrjgmi

nan

The use of antibiotics in the COVID-19 pandemic will inevitably exacerbate AMR, and could ultimately lead to more deaths and morbidity as an unintended consequence of this already tragic pandemic. Although AMR was already spreading rapidly before the emergence of COVID-19 4 , the impact of the pandemic may be more pronounced in low-and-middleincome countries (LMICs) due to the lack of antimicrobial stewardship, limited clinical microbiology capacity, and poorly regulated access to antibiotics amongst the many other challenges faced by health systems in LMICs. 5 The prevalence of resistant bacterial strains is higher in mobile populations such as travellers, migrants and refugees, who may be carriers for months after returning home. 6, 7 Amongst them are groups of vulnerable people who are disproportionately at risks to COVID-19, putting them at higher risks of complications if they experience secondary bacterial infections. 8 

number of countries contribute data revealing disturbing rates of antimicrobial resistance. 1

Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing

Modelling the effect of a dengue vaccine on reducing the evolution of resistance against antibiotic due to misuse in dengue cases

Global geographic trends in antimicrobial resistance: the role of international travel

Antimicrobial Resistance in the Asia Pacific region: a meeting report

Patient care without borders: a systematic review of medical and surgical tourism

Antibiotic resistance patterns of Escherichia coli in migrants vs non-migrants: a study of 14 561 urine samples

Refugee and migrant health in the COVID-19 response

Clinical Management of COVID-19: Interim Guidance. Geneva: World Health Organisation

No conflict of interest to declare.

No grant funding was used to support the writing of this manuscript.